SEP 10, 2019 12:36 PM PDT

Early onset colorectal cancer on the rise

New research from the American Cancer Society and recently published in Gut shows that colorectal cancer in young adults is on the rise in high-income countries. The study was conducted by Rebecca Siegel, MPH, and her colleagues.

Siegel’s team of researchers was interested in finding out more about early onset colorectal cancer on a global scale. To do so, they used cancer incidence registries to look at data for colorectal cancer occurrence in adults under 50 versus adults over 50. Their analysis combined data for 43 countries covering six continents.

Because of the general trend that we are seeing globally of declining or stable numbers of colorectal cancer diagnoses in adults over 50, the researchers were surprised to find the opposite happening in a significant number of countries for adults under 50. As they report in the study:

“In nine countries, specifically, the rise in early-onset CRC was in contrast to trends in those 50 and older, which were either dropping (Australia, New Zealand, Canada, Germany, and United States) or stable (Denmark, Slovenia, Sweden, and United Kingdom). In all but one of these countries with long-term data, the uptick in early-onset CRC began in the mid-1990s. In addition, in three countries (Cyprus, Netherlands, and Norway) where incidence rose in both younger and older age groups, the increase in young adults was twice as steep as that in older adults and also began in the mid-1990s.”

Why would more younger people be receiving more diagnoses of colorectal cancer across the board? The authors surmise that changes in early-life exposures are increasing the risk of colorectal cancer (CRC).

"These patterns potentially signal changes in early-age exposures conducive to large bowel carcinogenesis and highlight an urgent need for research to explore the potentially unique etiology of young-onset CRC," said Ms. Siegel. "Although the absolute risk of CRC in adults younger than 50 years is low relative to older adults, disease trends in young age groups are a key indicator of recent changes in risk factor exposures and often foreshadow the future cancer burden."

Why is early onset CRC on the rise? Photo: Pixabay

The authors urge that more investigation into this topic is necessary in order to understand the long-term trends at play. Because colorectal cancer is the third most commonly diagnosed cancer worldwide, constructing a fuller image of CRC and early onset CRC is crucial in mitigating premature morbidity. Already CRC is on the decline in those over 50, assumedly because of improved screening; perhaps, the authors say, these screenings should extend to those under 50 as well.

Sources: Science Daily, Gut

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 31, 2021
Genetics & Genomics
Targeting Aneuploidy in Cancer Cells
JAN 31, 2021
Targeting Aneuploidy in Cancer Cells
Cancer is typically related to problems in cells' genomes that lead to uncontrolled cell growth, and the formation of tu ...
FEB 18, 2021
Cancer
Measuring the psychological impacts of cancer and additional comorbidities
FEB 18, 2021
Measuring the psychological impacts of cancer and additional comorbidities
In a new analysis of 2017 data from the National Health Survey of Spain published in Psycho-Oncology, researchers find t ...
MAR 02, 2021
Cell & Molecular Biology
Koala Retrovirus Can Rewrite the Genome & Trigger Cancer
MAR 02, 2021
Koala Retrovirus Can Rewrite the Genome & Trigger Cancer
Retroviruses can infect cells and insert themselves into the genetic code of their host. Sometime in the past 50,000 yea ...
MAR 22, 2021
Cell & Molecular Biology
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
MAR 22, 2021
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
Immunotherapy aims to make a patient's immune cells better at fighting cancer. The immune system has to be used carefull ...
APR 10, 2021
Cancer
Administration of this immune-stimulating drug pre-surgery could help pancreatic cancer patients
APR 10, 2021
Administration of this immune-stimulating drug pre-surgery could help pancreatic cancer patients
New findings support the administration of a CD40 immune-stimulating drug to early-stage pancreatic cancer patients in a ...
MAY 13, 2021
Genetics & Genomics
Explore Ways to Enhance Biomarker Discovery Research
MAY 13, 2021
Explore Ways to Enhance Biomarker Discovery Research
Enhance your existing research or discover new methods with a suite of NGS tools and techniques to find and characterize ...
Loading Comments...